This inventor holds 1 USPTO granted patent. Top assignee: Tasly Pharmaceutical Group Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jianchun Wang and a Pharmaceutical Composition for Myocardial Ischemia.
Introduction
Jianchun Wang is an inventor associated with Tianjin, China, and Tasly Pharmaceutical Group Co., Ltd. His listed patent concerns a pharmaceutical composition intended for the prevention and treatment of myocardial ischemia.
Latest Patents
Wang’s listed patent is “Pharmaceutical Composition for Treating Myocardial Ischemia and Preparation Method Therefor.” It describes a composition containing 250–700 parts by weight of Salvia miltiorrhiza medicinal material, 50–150 parts of Radix notoginseng medicinal material, 3–9 parts of synthetic borneol, and 25–100 parts of ranolazine. The patent also describes using the composition to prepare a medicine for preventing and/or treating myocardial ischemia. Wang is credited with 1 patent in the information provided.
Career Highlights
The available information connects Wang’s patent work with Tasly Pharmaceutical Group Co., Ltd. and pharmaceutical research focused on myocardial ischemia. The patent combines traditional medicinal materials with ranolazine in a proposed therapeutic composition.
Collaborations
He Sun and Kaijing Yan are identified as Wang’s coworkers. The information provided does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Jianchun Wang’s listed invention focuses on a multi-ingredient pharmaceutical composition proposed for preventing and treating myocardial ischemia, reflecting his connection to pharmaceutical innovation at Tasly Pharmaceutical Group Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile